Beryl Capital Management LLC 13D and 13G filings for Calidi Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-13 11:23 am Sale |
2022-12-31 | 13G | Calidi Biotherapeutics, Inc. CLDI |
Beryl Capital Management LLC | 0 0.000% |
-116,000 (Position Closed) |
Filing |
| 2022-02-14 2:50 pm Purchase |
2021-12-31 | 13G | Calidi Biotherapeutics, Inc. CLDI |
Beryl Capital Management LLC | 116,000 5.000% |
116,000 (New Position) |
Filing |